These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

10406 related articles for article (PubMed ID: 1333318)

  • 21. Immunohistochemical detection of p53 in melanomas with rare p53 gene mutations is associated with mdm-2 overexpression.
    Poremba C; Yandell DW; Metze D; Kamanabrou D; Böcker W; Dockhorn-Dworniczak B
    Oncol Res; 1995; 7(7-8):331-9. PubMed ID: 8747596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated left ventricular filling abnormalities may predict interleukin-2-induced cardiovascular toxicity.
    Citterio G; Fragasso G; Rossetti E; Di Lucca G; Bucci E; Foppoli M; Guerrieri R; Matteucci P; Polastri D; Scaglietti U; Tresoldi M; Chierchia SL; Rugarli C
    J Immunother Emphasis Tumor Immunol; 1996 Mar; 19(2):134-41. PubMed ID: 8732696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three different states of the chromatin structure of the mouse peripherin gene.
    Karpov V; Fauquet M; Lecomte MJ; Portier MM
    J Neurosci Res; 1996 Apr; 44(2):115-23. PubMed ID: 8723219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delaminomycins, novel extracellular matrix receptor antagonist. IV. Structure-activity relationships of delaminomycins and derivatives.
    Ueno M; Amemiya M; Yamazaki K; Iijima M; Osono M; Someno T; Iinuma H; Hamada M; Ishizuka M; Takeuchi T
    J Antibiot (Tokyo); 1993 Jul; 46(7):1156-62. PubMed ID: 8360111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Psoriasis Disability Index--further analyses.
    Kent G; al-Abadie M
    Clin Exp Dermatol; 1993 Sep; 18(5):414-6. PubMed ID: 8252760
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic evaluation of intracranial metastasis in malignant melanoma.
    Saha S; Meyer M; Krementz ET; Hoda S; Carter RD; Muchmore J; Sutherland C
    Ann Surg Oncol; 1994 Jan; 1(1):38-44. PubMed ID: 7834426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of p53 protein in malignant melanoma: clinicopathological and prognostic implications.
    Weiss J; Heine M; Körner B; Pilch H; Jung EG
    Br J Dermatol; 1995 Jul; 133(1):23-31. PubMed ID: 7669636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell death by oxidative stress and ascorbic acid regeneration in human neuroectodermal cell lines.
    De Laurenzi V; Melino G; Savini I; Annicchiarico-Petruzzelli M; Finazzi-Agrò A; Avigliano L
    Eur J Cancer; 1995; 31A(4):463-6. PubMed ID: 7576946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies of cellular mediated immunity in malignant melanoma patients by Leukocyte Adherence Inhibition Test.
    Müller S; Ernst TM
    Arch Dermatol Res; 1980; 268(2):167-81. PubMed ID: 7425670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical management of regional lymph nodes in cutaneous melanoma.
    Balch CM
    J Am Acad Dermatol; 1980 Nov; 3(5):511-24. PubMed ID: 7217379
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serological response of melanoma patients receiving melanoma cell vaccines. I. Autologous cultured melanoma cells.
    Livingston PO; Watanabe T; Shiku H; Houghton AN; Albino A; Takahashi T; Resnick LA; Michitsch R; Pinsky CM; Oettgen HF; Old LJ
    Int J Cancer; 1982 Oct; 30(4):413-22. PubMed ID: 7141736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Complex therapy of melanoma metastases in the lung].
    Nivinskaia MM; Iavorskiĭ VV; Musatov VK; Ogurtsova IN
    Med Radiol (Mosk); 1984 Feb; 29(2):7-10. PubMed ID: 6700393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential susceptibility and cytopathic alterations induced by PTT. 119, a new cancericidal compound, p-fluoro-Phe-L-Phe-m-bis-(2-chloroethyl)amino-L-Phe-Met ethoxy HCl.
    Yagi MJ; Bekesi JG
    Biomed Pharmacother; 1983; 37(7):329-38. PubMed ID: 6667339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degree of differentiation and blood vessel proximity in B16 melanoma.
    Paulus G; Hong LX; Atassi G; Buyssens N
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1982; 39(2):229-38. PubMed ID: 6123193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of low phenylalanine-tyrosine diets on S91 mouse melanomas.
    Demopoulos HB
    J Natl Cancer Inst; 1966 Aug; 37(2):185-90. PubMed ID: 5912613
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of endoxan & 5-fluorouracil on the primary culture of melanoma cells.
    Shee M
    Indian J Exp Biol; 1969 Jul; 7(3):175-6. PubMed ID: 5359075
    [No Abstract]   [Full Text] [Related]  

  • 37. [Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)].
    Egorov LV; Terent'eva TG; Rudneva NA; Egorenko GG; Ivanitskaia LP
    Antibiot Med Biotekhnol; 1985 Dec; 30(12):918-27. PubMed ID: 3866512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of nitrogen dioxide and ozone on blood-borne cancer cell colonization of the lungs.
    Richters A
    J Toxicol Environ Health; 1988; 25(3):383-90. PubMed ID: 3184205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cryotherapy of metastatic B16 melanoma. Consequences of the immunogenic potential].
    Bellangeon M; Hosni M; Tétu A; Santini R; Pacheco H
    C R Seances Soc Biol Fil; 1988; 182(5):453-7. PubMed ID: 2977965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice.
    Abe F; Schneider M; Black PL; Talmadge JE
    Cancer Immunol Immunother; 1989; 29(4):231-6. PubMed ID: 2752391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 521.